News | Ultrasound Women's Health | December 22, 2015

Seno Medical Instruments Announces Imagio Breast Imaging System Pilot Study Data

Results demonstrate potential for opto-acoustic device to improve downclassification of suspicious breast masses, prevent biopsies and follow-up exams

Seno Medical, Imagio breast imaging system, opto-acoustic device, PIONEER Study, pilot data, RSNA 2015

December 22, 2015 — Seno Medical Instruments Inc. announced results of its pilot study portion of the PIONEER pivotal study at the 2015 Radiological Society of North America (RSNA) annual meeting. The pilot study demonstrated the potential of the company's Imagio opto-acoustic (OA) breast imaging system to improve physicians' ability to accurately classify benign breast masses compared to traditional ultrasound methods.

The 100-subject pilot study was conducted as the initial part of a larger U.S.-based, multicenter PIONEER pivotal study of over 2,000 subjects. The PIONEER study is being conducted to demonstrate the ability of the Imagio OA breast imaging system to downgrade BI-RADS (Breast Imaging-Reporting and Data System) scores. Specifically, the study is investigating whether masses originally scored BI-RADS (BR) 4a or 4b (in which a suspicious abnormality is discovered and a biopsy is recommended) could be downgraded to either BR 3 (probably benign, <2 percent likelihood of malignancy with short-interval follow-up recommended) or 2 (benign) and if masses coded BR 3 could be downgraded to 2.

Seven independent breast radiologist readers (IRs) and an expert radiologist (ER) trainer blindly assessed 102 masses from the pilot study cases using only Imagio OA images. Among these subjects, there were 75 biopsied masses (39 benign, 36 malignant). Gray-scale ultrasound images were taken with the Imagio system's conventional ultrasound immediately prior to the OA exam. These images were designated the internal ultrasound control (IUC). Later, the IRs assigned a BR score to these images.

Using OA, the IRs downgraded conventional diagnostic ultrasound findings classified BR 3 masses to BR 2 in 33 percent of cases, BR 4a masses to BR 2 or 3 in 53 percent of cases, and BR 4b masses to BR 3 or 2 in 33 percent of cases. Using OA, the IRs downgraded BI-RADS categories of the internal ultrasound control-classified BR 3 masses to BR 2 in 43 percent of cases, BR 4a to either BR 3 or 2 in 43 percent of cases and BR 4b masses to either BR 3 or 2 in 13 percent of cases. OA had 97.6 percent sensitivity and 44.4 percent specificity.

"Downgrading benign masses classified as BR 4b (moderate suspicion), 4a (low suspicion) and 3 without missing cancers is an unmet need that the Imagio OA breast imaging system can potentially help address," said Erin Neuschler, M.D., Northwestern Medicine radiologist, assistant professor of radiology at the Northwestern University Feinberg School of Medicine and the co-principal investigator of the PIONEER Study. "If these pilot findings are verified after the completion of the multicenter PIONEER Study, we will have confirmation that the Imagio OA breast imaging system could help women not only avoid biopsy procedures but also multiple short interval follow-up ultrasound exams over two years."

The Imagio OA breast imaging system was designed to identify the two functional hallmarks of cancer: the presence of abnormal blood vessels (tumor angiogenesis) and the relative reduction in oxygen content of blood that occurs in cancer compared to benign masses and normal tissues. The technology used by the Imagio system is non-invasive and does not require patient exposure to contrast agents, ionizing radiation (X-ray) or radio-isotopes, which are required for other modalities that are capable of functional imaging, including magnetic resonance imaging (MRI) or positron emission tomography (PET).

For more information: www.senomedical.com

Related Content

Images from computed tomography (CT) colonography show segmented abdominal aortic calcification measured with semiautomated CT tool on coronal image. Within region of interest over aorta selected by user, tool automatically segments and quantifies aortic calcification (shown in blue). 

Image Credit: O’Connor S D, Graffy P M, Zea R, et al. Does nonenhanced CT-based quantification of abdominal aortic calcification outperform the Framingham Risk Score in predicting cardiovascular event sin asymptomatic adults? Radiology doi: 10.1148/radiol.2018180562. Published online Oct. 2, 2018. © RSNA.

News | Computed Tomography (CT) | October 12, 2018
Computed tomography (CT)-based measures of calcification in the abdominal aorta are strong predictors of heart attacks...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
Carestream Digital X-ray System Deployed at Remote Antarctic Station
News | Digital Radiography (DR) | October 10, 2018
Carestream is providing a DRX-Transportable System/Lite for the Italian-French Concordia scientific station in...
Canon Medical Launches Healthy Sonographer Program
News | Ultrasound Imaging | October 10, 2018
Canon Medical Systems USA Inc. launched an all-new program designed to help reduce the leading causes of pain and...
"Where's My Mammogram?" Campaign Helps Women Own Breast Health Records
News | Breast Imaging | October 10, 2018
October 10, 2018 — Mammosphere launched “Where’s My Mammogram?,” a public service campaign to help women obtain copie
DenseBreast-info.org Launches European Expansion
News | Breast Density | October 10, 2018
DenseBreast-info.org (DB-I) announced the launch of its international expansion for European medical providers. The...
FDA Clears Magnetom Sola 1.5T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | October 09, 2018
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sola, a 1.5 Tesla magnetic resonance imaging (MRI...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
CHI Franciscan Launches Washington State's First AI-Powered Hospital Mission Control Center
News | Artificial Intelligence | October 08, 2018
CHI Franciscan Health and GE Healthcare have joined forces to implement a NASA-style "Mission Control" command center...
ASTRO 2018 Radiation Therapy Clinical Trials
Feature | ASTRO | October 08, 2018
October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies tha